Nevertheless, the anti-tumor mechanism of Lm-LLO-CD105A strongly relied on CD8+ T cells as the anti-tumor efficacy of Lm-LLO-CD105A was lost upon antibody-mediated depletion of CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.